Sabinsa Corporation today announced that Arumugam Sivakumar, Ph.D., will present “Lactospore: Highlights of a room temperature stable and versatile probiotic” at the Probiotech2008 conference being held June 23-24 in Nantes, France. During his session on June 23, Dr. Sivakumar will discuss the applications and potential benefits of Lactospore®, Sabinsa’s patented lactic acid bacillus preparation.
Lactospore promotes improved digestion by increasing the amount of enzymes in the stomach and intestines and creating a balance of intestinal flora. It also works to significantly reduce pathogenic bacteria, yeast and parasites, decreasing incidents of diarrhea, constipation and dyspepsia. Lactospore produces the predominantly desired form of L(+) Lactic acid and thus, unlike other probiotics, does not lead to acidosis in the body. In addition, Lactospore does not produce side effects like gas or bloating, as is common with other probiotics. Products containing Lactospore do not need to be refrigerated to retain their maximum potency since the Bacillus coagulans microorganisms have been manufactured to retain a relatively strong outer layer that protects against drastic environmental changes. This means the microorganisms are not destroyed when exposed to bile or gastric secretions. Lactospore contains only a Bacillus coagulans culture and is preservative, GMO and allergen-free as well as certified Kosher. For more information visit www.lactospore.com.
Probiotech 2008 provides attendees with updated information on industry applications, scientific research, health claims and regulation issues surrounding probiotics and prebiotics. For more information on this conference visit www.probiotech.eu/2008.
